Screening for Vancomycin-Resistant Enterococci in Patients Admitted to Hospital: Clinical Effectiveness, Cost-Effectiveness, and Guidelines


( Last Updated : July 17, 2019)
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1362-000

Details


Question

  1. What is the clinical effectiveness of selective screening versus universal screening or no screening of vancomycin-resistant enterococci in patients admitted to hospital?
  2. What is the cost-effectiveness of selective screening versus universal screening or no screening of vancomycin-resistant enterococci in patients admitted to hospital?
  3. What are the evidence-based guidelines regarding screening of vancomycin-resistant enterococci in patients admitted to hospital?

Key Message

One health technology assessment, two non-randomized studies, and one economic evaluation were identified regarding the selective screening versus universal screening or no screening of vancomycin-resistant enterococci in patients admitted to hospital. In addition, two evidence-based guidelines were identified regarding the screening of vancomycin-resistant enterococci in patients admitted to hospital. No systematic reviews, meta-analyses, or randomized controlled trials were identified.